JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emmerson, J. L.
Right arrow Articles by Miya, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emmerson, J. L.
Right arrow Articles by Miya, T. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 137, Issue 2, 148-155, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


THE METABOLISM AND EXCRETION OF S35-CHLORPROMAZINE BY THE RAT

John L. Emmerson 1 and Tom S. Miya 1

1 Department of Pharmacology, Purdue University, Lafayette, Indiana

The metabolic fate of S35-chlorpromazine was studied in the rat. From 40 to 50% of the dose was excreted in the urine and an equivalent amount in the feces. The excretion of radioactivity was maximal during the first 36 hours and was essentially complete within 72 hours.

Four excretion products were determined qualitatively by chromatography and quantitatively as a percent of the dose: chlorpromazine (12.3%); chlorpromazine sulfoxide (5.0%); chlorpromazine sulfoxide secondary amine (5.2%); and chlorpromazine sulfoxide primary amine (2.3%). Rats excreted more of the latter metabolite and less chlorpromazine sulfoxide following pretreatment for 2 weeks with chlorpromazine.

Submitted on March 28, 1962







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.